Related Experiment Video
Updated: Jun 15, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
[Early deep brain stimulation for Parkinson's disease].
A Schnitzler1, G Fuchs, H Baas
1Zentrum für Bewegungsstörungen und Neuromodulation der Neurologischen Klinik, Institut für Klinische Neurowissenschaften und Medizinische Psychologie, Universitätsklinikum der Heinrich-Heine-Universität Düsseldorf, Düsseldorf. Alfons.Schnitzler@uni-duesseldorf.de
Fortschritte Der Neurologie-Psychiatrie
|March 3, 2010
Summary
Subthalamic nucleus deep brain stimulation (STN-DBS) improves Parkinson's disease motor symptoms and quality of life. Early STN-DBS may offer greater benefits and prevent psychosocial decline compared to delayed treatment.
Area of Science:
- Neurology
- Neurosurgery
Context:
- Advanced Parkinson's disease (PD) presents with levodopa-induced motor complications.
- Subthalamic nucleus deep brain stimulation (STN-DBS) is an established treatment for PD.
- Current treatment delays range up to 14 years post-diagnosis.
Purpose:
- To evaluate the efficacy of early STN-DBS compared to best medical treatment.
- To determine if earlier intervention improves motor deficits and quality of life.
- To assess the impact on psycho-social adaptation and duration of therapeutic benefits.
Summary:
- Randomized controlled trials demonstrate STN-DBS superiority over best medical treatment for motor fluctuations and quality of life.
- Pilot data suggest earlier STN-DBS (at 7 years disease duration) may enhance motor improvement and quality of life.
- The EARLYSTIM trial is investigating early STN-DBS versus best medical treatment.
Impact:
- Early STN-DBS may prevent disease-related psycho-social decline.
- Timely intervention could extend the period of STN-DBS efficacy.
- Results from the EARLYSTIM trial will clarify the benefits of early STN-DBS for Parkinson's disease management.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.